Oncotarget New Study: Nanoparticles Target Acute Myeloid Leukemia Researchers developed a nanoparticle-based T cell engager (nanoTCE) technology believed to be capable of targeting... read more September 15, 2021
Oncotarget New Study: How Exercise Boosted Chemotherapy in Mice A new study demonstrates how exercise impacts a highly-prescribed chemotherapeutic agent, doxorubicin, in murine models... read more September 1, 2021
Oncotarget New Study: How Worms Can Detect Early Pancreatic Cancer Researchers from Japan used Caenorhabditis elegans (a one millimeter roundworm) to detect early pancreatic ductal... read more August 18, 2021
Oncotarget Epigenetic Signatures Differentiate Leiomyosarcoma Subtypes In the cover paper chosen for Oncotarget’s Volume 12, Issue 16, researchers from Yale... read more August 4, 2021
Oncotarget Metal Compounds Induce DNA Instability In Cancer Cells Telomeres are the protective end-caps that seal the DNA’s genetic information. Located at... read more July 21, 2021
Oncotarget Acid Reflux Drug Exhibits Anticancer Activity In the cover paper of Oncotarget's Volume 12, Issue 14, researchers repurposed an over-the-counter acid... read more July 7, 2021
Oncotarget Amino Acid Transporter May Be Promising Anti-Cancer Target Researchers used CRISPR-Cas9 and a number of other biological analyses to investigate the oncogenetic tendency... read more June 23, 2021
Oncotarget A New Potential Network of Biomarkers Useful Across Sarcomas Researchers examined five potential prognostic and therapeutic biomarkers across 18 different histologic subtypes of sarcoma... read more April 14, 2021
Oncotarget The First Study on CABYR Isoforms in Colorectal Cancer Researchers evaluate CABYR isoforms a/b and c mRNA expression in colorectal cancer in hopes... read more March 3, 2021
Oncotarget Pharmacological Study of Z-endoxifen in Patients with Advanced Tumors In this phase 1 clinical study, the safety, tolerability, and efficacy of daily oral doses... read more February 17, 2021